Abstract
Purpose of Review
The purpose of this article is to review the Mayo Clinic criteria for diagnosis, differential diagnoses, epidemiology, pathogenesis, imaging, treatment, and prognosis for this condition.
Recent Findings
Takotsubo cardiomyopathy (TCMP) often poses a diagnostic dilemma in the emergency department (ED) and in the intensive care unit (ICU) setting. TCMP is virtually indistinguishable from acute coronary syndrome (ACS).
Summary
Further research is needed to study the pathogenesis of this condition and to investigate whether genetic or serologic markers could be used to identify individuals at risk for this condition.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction: Nomenclature and Historical Perspective
Takotsubo cardiomyopathy (TCMP) was first recognized in Japan in 1990 [1, 2]. It is known by various names: stress induced cardomyopathy, apical ballooning, and broken heart syndrome. The term takotsubo means an octopus trap in Japanese, as the left ventricle (LV) during systole assumes the shape of one. While the mid to apical segments are hypokinetic, the base is hypercontractile. TCMP is characterized by transient, regional wall motion abnormality (WMA) which extends beyond the perfusion of a single coronary artery [1,2,3, 4••, 5•].
Moreover, the WMA occurs in the absence of obstructive coronary artery disease (CAD) supplying this territory [4••, 5•, 6].
Clinical Presentation
Acute onset of substernal chest pain is the most common presenting symptom to the emergency department (ED), while others may present with dyspnea, acute heart failure, tachyarrhythmia, bradyarrhythmia, sudden cardiac death, left ventricular outflow (LVOT) obstruction, or acute mitral regurgitation. LVOT obstruction is due to basal hyperkinesis. Patients with LVOT obstruction may present with a late systolic murmur and shock. Ten percent of patients suffered cardiogenic shock. Transient ischemic attack and stroke have also been reported [3, 4••, 6,7,8,9,10].
Criteria for Diagnosis
The diagnosis of TCMP may be suspected if the clinical severity exceeds the degree of cardiac biomarker elevations, but this diagnosis is generally not made in the ED, as the presentation is indistinguishable from ACS, and requires sequential assessment of ventricular systolic function, usually with echocardiogram, to confirm that the ventricular dysfunction is transient [4••, 5•, 11].
The current diagnosis of CMP requires meeting all four of the Mayo Clinic criteria for diagnosis [11, 12].
-
1.
New EKG abnormalities, which may include ST elevation or depression, T wave inversion, QT prolongation, or nonspecific STT abnormalities
-
2.
Absence of obstructive coronary artery disease (CAD) in the distribution of the wall motion abnormality
-
3.
Transient left ventricular wall motion abnormalities extending beyond a single coronary artery distribution
-
4.
Absence of pheochromocytoma and myocarditis
Epidemiology
One to two percent of acute myocardial infarctions have been retrospectively reclassified as TCMP after coronary angiography and sequential assessment of the left ventricular systolic function [6, 9, 11]. It tends to affect older women, with a mean age of 66.4 years. 89.9% of TCMP has been diagnosed in women [4••].
While the nomenclature implies stress, an international registry identified physical stress in 36%, emotional trigger in 27.7%, and combined trigger in 7.8% of patients. In 28.5%, no trigger was identified [4••]. Fifteen percent of patients in the international registry were recognized as having concomitant CAD [4••, 11].
Pathogenesis
The etiology of TCMP is unknown. It has been postulated that catecholamine-induced myocardial stunning, coronary spasm, or microvascular dysfunction as potential mechanism for causing transient ventricular dysfunction. Increased plasma norepinephrine was found in 26 of 35 patients (74%) in one study [5•, 7, 8, 12, 13]. However, plasma catecholamine levels have not been found to be uniquely higher in TCMP vs. ACS patients in another study [14]. Abnormal TIMI frame counts, suggestive of coronary vasospasm during coronary angiography has also been reported [15]. One study reported a preponderance of chronic affective or neurologic disorder, such as anxiety, headaches, and seizures, in 55.8% of patients with TCMP, vs. 25.7% of patients with ACS [4••]. Genetic predisposition has also been observed [16,17,18,19,20,21].
Diagnostic Testing and Treatment
The initial testing and treatment for TCMP should be the same as for ACS. EKG, cardiac biomarkers, B-type natrieuretic peptide or NT pro-BNP, and chest X-Ray should be obtained immediately upon arrival to the ED [4••, 5•, 12]. Coronary angiography (CA) should be undertaken as soon as possible in the appropriate patient. If the criteria are met for ST elevation myocardial infarction (STEMI) and CA is not available, thrombolytic and antiplatelet therapy should be initiated immediately. Beta blocker is also indicated as acute treatment. However, there has not been any data on long-term benefit of beta blocker, as 50% of patients with recurrent TCMP were taking beta blocker [22•]. Heart failure and dysrhythmia should be treated with conventional therapy for these conditions.
Echocardiogram showed mid to apical hypokinesis, akinesis, or dyskinesis in 81.7% of patients. These individuals exhibited basal hyperkinesis. 14.6% had mid ventricular, 2.2% had basal, and 1.5% had anterolateral hypokinesis. Mean LVEF was 41% [4••]. One third of patients had combined left and right ventricular (RV) systolic dysfunction [4••, 6, 7, 23,24,25]. Those with combined LV and RV systolic dysfunction tend to have a lower LVEF of 40%, vs. 48% in patients with sole LV involvement [25].
Cardiac magnetic resonance imaging (CMR) may also be considered for distinguishing TCMP from myocardial infarction (MI) and myocarditis. In MI, there is intense subendocardial or transmural late gadolinium enhancement (LGE). In myocarditis, LGE is usually in a patchy distribution. In TCMP, LGE is absent. Myocardial edema is less common in TCMP than in MI and myocarditis. CMR is also helpful in identifying cardiac thrombus and RV involvement [24, 25].
Positron emission tomography (PET) can also be used to distinguish TCMP from myocardial infarction (MI), as the former will show normal perfusion and reduced glucose utilization, known as an inverse flow metabolism mismatch, whereas in MI, both perfusion and glucose utilization are reduced [26].
Differential Diagnoses
Other conditions mimicking TCMP include cocaine-induced ACS, distinguishable through toxicology; myocarditis, which has a slower recovery than TCMP; and pheochromocytoma, a condition where patients often exhibit tachycardia, sweating, headaches, and weight loss [27].
Prognosis
TCMP patients who show RV involvement tend to have a lower median LVEF of 40% (vs. 48%), and a more serious condition. Cardiogenic shock is more common in this subgroup.
Of 18,353 patients with TCMP, 4.1% died in the hospital (7.5% were men, 3.8% were women). They tend to be older men with peripheral arterial disease (PAD), had ventricular fibrillation or cardiac arrest, and lived in the northeast region [28]. Asians also have a higher mortality rate amongst various ethnic groups [29].
Conclusion and Summary
TCMP is indistinguishable from ACS upon presentation to the ED, and should be treated as such. Unlike ACS, the severity of this disease exceeds the level of biomarker elevation, and ventricular function recovers rather quickly, generally over the course of a week [30]. Mayo Clinic diagnostic criteria, imaging modalities, and clinical course distinguish TCMP from ACS, myocarditis, and pheochromocytoma. Older age, PAD, male gender, ventricular fibrillation, cardiac arrest, and RV involvement are predictors for a higher in-hospital mortality rate. While TCMP should be treated like heart failure with reduced EF, chronic beta blocker usage has not been observed to reduce the recurrence of this disorder [22•].
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Sato H, Taiteishi H, Uchida T. Takotsubo-type cardiomyopathy due to multivessel spasm. In: Clinical aspect of myocardial injury: from ischemia to heart failure, Kodama K, Haze K, Hon M (Eds), Kagakuhyouronsha, Tokyo 1990. p.56.
Dote K, Sato H, Tateishi H, et al. Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol. 1991;21:203.
Hachamovitch R, Chang JD, Kuntz RE, et al. Recurrent reversible cardiogenic shock triggered by emotional distress with no obstructive coronary disease. Am Heart J. 1995;129:1026.
•• Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373:929. Discusses information on takotsubo.
• Tsuchihashi K, Ueshima K, Uchida T, et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina pectoris-myocardial infarction investigations in Japan. J Am Coll Cardiol. 2001;38:11. Reviews a multicenter study on transient left ventricular ballooning.
Kurowski V, Kaiser A, von Hof K, et al. Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis. Chest. 2007;132:809.
Sharkey SW, Lesser JR, Zenovich AG, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005;111:472.
Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352:539.
Gianni M, Dentali F, Grandi AM, et al. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J. 2006;27:1523.
Barrera-Ramirez CF, Jimenez-Mazuecos JM, Alfonso F. Apical thrombus associated with left ventricular apical ballooning. Heart. 2003;89:927.
Prasad A, Dangas G, Srinivasan M, et al. Incidence and angiographic characteristics of patients with apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS-AMI trial: an analysis from a multicenter, international study of ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2014;83:343.
Bybee KA, Kara T, Prasad A, et al. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. 2004;141:858.
Nef HM, Möllmann H, Kostin S, et al. Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J. 2007;28:2456.
Madhavan M, Borlaug BA, Lerman A, et al. Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriuretic peptide and troponin levels. Heart. 2009;95:1436.
Bybee KA, Prasad A, Barsness GW, et al. Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol. 2004;94:343.
Pison L, De Vusser P, Mullens W. Apical ballooning in relatives. Heart. 2004;90:e67.
Kumar G, Holmes Jr DR, Prasad A. “Familial” apical ballooning syndrome (Takotsubo cardiomyopathy). Int J Cardiol. 2010;144:444.
Ikutomi M, Yamasaki M, Matsusita M, et al. Takotsubo cardiomyopathy in siblings. Heart Vessel. 2014;29:119.
Handy AD, Prasad A, Olson TM. Investigating genetic variation of adrenergic receptors in familial stress cardiomyopathy (apical ballooning syndrome). J Cardiol. 2009;54:516.
Sharkey SW, Maron BJ, Nelson P, et al. Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) cardiomyopathy. J Cardiol. 2009;53:53.
Novo G, Giambanco S, Guglielmo M, et al. G-protein-coupled receptor kinase 5 polymorphism and Takotsubo cardiomyopathy. J Cardiovasc Med (Hagerstown). 2015;16:639.
• Templin C, Napp LC, Ghadri JR. Takotsubo syndrome: underdiagnosed, underestimated, but understood? J OF THE Am Coll Cardiol. 2016;67:16. Discusses that additional studies are needed to fully understand and manage Takotsubo Syndrome.
Desmet WJ, Adriaenssens BF, Dens JA. Apical ballooning of the left ventricle: first series in white patients. Heart. 2003;89:1027.
Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA. 2011;306:277.
Haghi D, Athanasiadis A, Papavassiliu T, et al. Right ventricular involvement in Takotsubo cardiomyopathy. Eur Heart J. 2006;27:2433.
Testa M, Feola M. Usefulness of myocardial positron emission tomography/nuclear imaging in Takotsubo cardiomyopathy. World J Radiol. 2014;6:502.
Ako J, Sudhir K, Farouque HM, et al. Transient left ventricular dysfunction under severe stress: brain-heart relationship revisited. Am J Med. 2006;119:10.
Predictors of in-hospital mortality in patients with Takotsubo cardiomyopathy: Insights of the healthcare cost and utilization project. Poster. J of Amer Coll of Cardiol. 2016; 67:1
Racial differences and the risk of in-hospital mortality in Takotsubo cardiomhyopathy. Analysis form the national inpatient sample 2012 database. Poster. J of Amer Coll of Cardiol. 2016; 67:13
Park JH, Kang SJ, Song JK, et al. Left ventricular apical ballooning due to severe physical stress in patients admitted to the medical ICU. Chest. 2005;128:296.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Hui declares no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Heart Failure
Rights and permissions
About this article
Cite this article
Hui, G. Takotsubo Cardiomyopathy vs. Acute Coronary Syndrome in the Emergency Department Setting: a Review of Diagnostic Criteria and Outcomes. Curr Emerg Hosp Med Rep 5, 64–67 (2017). https://doi.org/10.1007/s40138-017-0129-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40138-017-0129-2